Uses of the drug Crondia 30 MR

Crondia 30 MR is a drug for the treatment of non-insulin dependent type 2 diabetes and cannot be controlled by conventional diet. Crondia 30 MR is available as a 30mg release tablet for oral administration.

Crondia 30 MR is an oral antidiabetic drug with the main ingredient being Gliclazide, a sulphonylurea group drug with effective blood sugar lowering effect. Gliclazide in particular and Sulphonylurea drugs in general help stimulate pancreatic cells to release insulin, thereby lowering blood sugar. Note: This medicine should only be used when the pancreas is still able to produce insulin.
Indications of Crondia 30MR: Used for type 2 diabetes (non-insulin dependent) when blood glucose control is not achieved by diet alone.

Crondia 30 MR is formulated as a release tablet that should be taken orally. The patient should swallow the tablet whole without crushing or chewing. Take the medicine with a glass of water before breakfast.
Dosage of Crondia 30 MR depends on each specific case, for example: weight, stress level, blood glucose index and possibly urine sugar of the patient. Dosage reference:
Recommended dose: 30-120mg (1-4 tablets)/day, taken only once before breakfast; Maintenance dose: 60mg (2 tablets)/day, taken once. Note:
To remember the drug schedule, it is best to take Crondia at the same time every day: Take 1 time only before breakfast (and breakfast after taking the medicine); Crondia can be used in combination with alpha-glucosidase inhibitors, biguanides or insulin, but close monitoring is required.

During treatment with Crondia 30 MR, users may encounter the following problems:
Headache; Nausea; Digestive disorders ; Itchy; Rash, rash; Joint pain, back pain, arthritis; Bronchitis ; Hypoglycemia (mild to moderate). Less common side effects include: Leukopenia, thrombocytopenia, agranulocytosis, anemia, skin and mucosal reactions.

Contraindications to use Crondia 30 MR for the following cases:
Hypersensitivity to Gliclazide and other components of the drug; Having type 1 diabetes Patients with severe liver failure; Patients with severe renal failure; Pregnant women; People who are in a coma or pre-coma due to diabetes; Are being treated with Miconazole tablets; Patients with severe infections; Patients with severe trauma; People undergoing major surgery. Be especially careful when using Crondia for the following subjects:
Women who are breastfeeding (should consult a doctor); Patients with hepatic impairment, renal impairment (consider dose reduction); Children; Elderly. Other notes
Patients still need to maintain a diet while taking Crondia 30 MR to increase the effectiveness of treatment (hypoglycemia); Hypoglycemia can lead to dizziness, temporary loss of consciousness, so do not drive or operate machinery or equipment while taking this medicine.

Concurrent use of Crondia 30 MR with the following drugs may increase the hypoglycemic effect of the active ingredient Gliclazide:
Other drugs to treat hyperglycemia; Medicines to treat heart failure or high blood pressure; Anti-fungal drugs; Medicines for the treatment of gastric and duodenal ulcers; Sulfonamide group antibiotics; Pain relievers or anti-arthritic drugs; Medicines for depression; The drug contains alcohol. In contrast, concomitant use of Crondia 30 Mr with the following drugs may reduce the hypoglycemic effect of Gliclazide:
Drugs for the treatment of central nervous system disorders; Anti-inflammatory drugs; Asthma medications; Drugs used in labor; Medicines to treat mammary gland disorders, heavy periods or endometriosis; In addition, Crondia 30 MR may increase the effectiveness of blood thinners such as Warfarin.
Above are the uses of Crondia 30 MR. Before using you need to consult and understand how to use the drug. If you have any questions, you can ask your prescribing doctor for answers.